Hakimian, M., and R. Noori. “The Relationship Between Pembrolizumab for the Treatment of PD-L1 Positive Advanced in Cell Lung Cancer”. International Pharmacy Acta, vol. 1, no. 1, Mar. 2018, pp. 154-, doi:10.22037/ipa.v1i1.20499.